Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Above averageAptar is a global leader in the design and manufacturing of drug and consumer product dosing, dispensing and protection technologies. Aptar serves diversified end markets including pharmaceutical, fragrance, facial skincare, color cosmetics, food, beverage, personal care and home care. Using proprietary design, engineering, materials science, and manufacturing capabilities, Aptar supports customers across these end markets by enabling safe, functional, and differentiated product and service delivery.
In the company’s own words · 10-K filed Feb 6, 2026 · SEC EDGAR
Business segments
Q2 2026 · $521.0MThe company’s own SEC segment disclosure.
- Pharma$230.7M44%
- Beauty$221.2M42%
- Closures$69.1M13%
AptarGroup, Inc. (ATR) reported revenue of $1.03B in Q2 2026 (quarter ended Jun 30, 2026), up 6.3% from the same quarter a year earlier. That came with a gross margin of 36% and net income of $88M (8.6% of revenue). For the full year FY2025, revenue was $3.78B (+5.4% year on year) and net income $392M. Its largest segment in Q2 2026 was Pharma at $231M, 44% of the disclosed total, just ahead of Beauty at 42%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Medical Instruments & Supplies
Ranks #6 of 19 by Smart Score